Tharimmune Short Long Term Debt Total vs Other Current Assets Analysis

THAR Stock

2.26 0.04 1.74%

Tharimmune financial indicator trend analysis is much more than just breaking down Tharimmune prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Tharimmune is a good investment. Please check the relationship between Tharimmune Short Long Term Debt Total and its Other Current Assets accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Tharimmune. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

To learn how to invest in Tharimmune Stock, please use our How to Invest in Tharimmune guide.

Short Long Term Debt Total vs Other Current Assets

Short Long Term Debt Total vs Other Current Assets Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Tharimmune Short Long Term Debt Total account and Other Current Assets. At this time, the significance of the direction appears to have fragmental relationship.

The correlation between Tharimmune's Short Long Term Debt Total and Other Current Assets is 0.55. Overlapping area represents the amount of variation of Short Long Term Debt Total that can explain the historical movement of Other Current Assets in the same time period over historical financial statements of Tharimmune, assuming nothing else is changed. The correlation between historical values of Tharimmune's Short Long Term Debt Total and Other Current Assets is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Short Long Term Debt Total of Tharimmune are associated (or correlated) with its Other Current Assets. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Other Current Assets has no effect on the direction of Short Long Term Debt Total i.e., Tharimmune's Short Long Term Debt Total and Other Current Assets go up and down completely randomly.

Correlation Coefficient

0.55

Relationship Direction	Positive
Relationship Strength	Weak

View All Relationships

Short Long Term Debt Total

Other Current Assets

Assets expected to be converted into cash, sold, or consumed either in one year or in the operating cycle, which are not included under standard current asset categories.

Most indicators from Tharimmune's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Tharimmune current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Tharimmune. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

To learn how to invest in Tharimmune Stock, please use our How to Invest in Tharimmune guide.At this time, Tharimmune's Selling General Administrative is relatively stable compared to the past year. As of 11/28/2024, Enterprise Value Over EBITDA is likely to grow to 1.16, while Issuance Of Capital Stock is likely to drop slightly above 2.2 M.

Tharimmune fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Tangible Assets	Net Debt	Retained Earnings	Accounts Payable	Cash	Long Term Debt	Cash And Short Term Investments	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Net Invested Capital	Short Long Term Debt	Total Current Assets	Capital Stock	Net Working Capital	Short Term Debt	Common Stock	Current Deferred Revenue	Non Currrent Assets Other
Total Assets		0.73	-0.11	0.09	0.97	0.94	-0.99	-0.99	0.59	1.0	0.51	1.0	0.78	-0.75	-0.01	1.0	-0.08	0.98	0.72	1.0	0.9	0.97	0.72	-0.7	0.78	-0.87
Short Long Term Debt Total	0.73		0.39	0.63	0.57	0.55	-0.67	-0.82	0.9	0.71	0.77	0.71	0.65	-0.28	0.55	0.73	0.48	0.62	0.94	0.73	0.77	0.59	0.94	-0.97	0.92	-0.47
Other Current Liab	-0.11	0.39		0.88	-0.34	-0.44	0.23	0.0	0.44	-0.14	0.6	-0.14	0.08	0.66	0.6	-0.12	0.94	-0.27	0.2	-0.11	-0.26	-0.31	0.2	-0.45	0.15	-0.03
Total Current Liabilities	0.09	0.63	0.88		-0.15	-0.22	0.03	-0.22	0.78	0.06	0.57	0.06	0.13	0.36	0.89	0.09	0.97	-0.08	0.54	0.09	0.01	-0.13	0.54	-0.66	0.5	-0.11
Total Stockholder Equity	0.97	0.57	-0.34	-0.15		0.99	-0.99	-0.93	0.41	0.98	0.34	0.98	0.74	-0.85	-0.21	0.97	-0.32	1.0	0.59	0.97	0.9	1.0	0.59	-0.52	0.66	-0.83
Net Tangible Assets	0.94	0.55	-0.44	-0.22	0.99		-0.97	-0.89	0.38	0.95	0.29	0.95	0.68	-0.88	-0.23	0.94	-0.39	0.98	0.58	0.94	0.92	0.99	0.58	-0.5	0.64	-0.75
Net Debt	-0.99	-0.67	0.23	0.03	-0.99	-0.97		0.97	-0.51	-0.99	-0.43	-0.99	-0.79	0.81	0.11	-0.99	0.2	-1.0	-0.68	-0.99	-0.92	-0.99	-0.68	0.62	-0.74	0.83
Retained Earnings	-0.99	-0.82	0.0	-0.22	-0.93	-0.89	0.97		-0.69	-0.98	-0.58	-0.98	-0.81	0.69	-0.11	-0.99	-0.05	-0.95	-0.8	-0.99	-0.9	-0.93	-0.8	0.78	-0.84	0.83
Accounts Payable	0.59	0.9	0.44	0.78	0.41	0.38	-0.51	-0.69		0.56	0.58	0.56	0.44	-0.25	0.8	0.59	0.63	0.46	0.91	0.59	0.58	0.41	0.91	-0.89	0.9	-0.42
Cash	1.0	0.71	-0.14	0.06	0.98	0.95	-0.99	-0.98	0.56		0.5	1.0	0.79	-0.76	-0.05	1.0	-0.11	0.99	0.69	1.0	0.9	0.98	0.69	-0.68	0.75	-0.87
Long Term Debt	0.51	0.77	0.6	0.57	0.34	0.29	-0.43	-0.58	0.58	0.5		0.5	0.38	0.16	0.29	0.5	0.57	0.39	0.5	0.51	0.43	0.38	0.5	-0.86	0.46	-0.44
Cash And Short Term Investments	1.0	0.71	-0.14	0.06	0.98	0.95	-0.99	-0.98	0.56	1.0	0.5		0.79	-0.76	-0.05	1.0	-0.11	0.99	0.69	1.0	0.9	0.98	0.69	-0.68	0.75	-0.87
Common Stock Shares Outstanding	0.78	0.65	0.08	0.13	0.74	0.68	-0.79	-0.81	0.44	0.79	0.38	0.79		-0.54	-0.06	0.78	-0.03	0.76	0.67	0.78	0.73	0.75	0.67	-0.5	0.7	-0.63
Non Current Liabilities Total	-0.75	-0.28	0.66	0.36	-0.85	-0.88	0.81	0.69	-0.25	-0.76	0.16	-0.76	-0.54		0.22	-0.76	0.56	-0.83	-0.47	-0.75	-0.76	-0.83	-0.47	0.18	-0.55	0.58
Other Current Assets	-0.01	0.55	0.6	0.89	-0.21	-0.23	0.11	-0.11	0.8	-0.05	0.29	-0.05	-0.06	0.22		-0.01	0.81	-0.16	0.59	-0.01	0.05	-0.21	0.59	-0.56	0.54	0.12
Other Stockholder Equity	1.0	0.73	-0.12	0.09	0.97	0.94	-0.99	-0.99	0.59	1.0	0.5	1.0	0.78	-0.76	-0.01		-0.08	0.98	0.72	1.0	0.9	0.97	0.72	-0.7	0.78	-0.86
Total Liab	-0.08	0.48	0.94	0.97	-0.32	-0.39	0.2	-0.05	0.63	-0.11	0.57	-0.11	-0.03	0.56	0.81	-0.08		-0.25	0.34	-0.08	-0.18	-0.3	0.34	-0.55	0.29	-0.01
Net Invested Capital	0.98	0.62	-0.27	-0.08	1.0	0.98	-1.0	-0.95	0.46	0.99	0.39	0.99	0.76	-0.83	-0.16	0.98	-0.25		0.62	0.98	0.9	1.0	0.62	-0.57	0.69	-0.85
Short Long Term Debt	0.72	0.94	0.2	0.54	0.59	0.58	-0.68	-0.8	0.91	0.69	0.5	0.69	0.67	-0.47	0.59	0.72	0.34	0.62		0.72	0.81	0.59	1.0	-0.84	0.99	-0.4
Total Current Assets	1.0	0.73	-0.11	0.09	0.97	0.94	-0.99	-0.99	0.59	1.0	0.51	1.0	0.78	-0.75	-0.01	1.0	-0.08	0.98	0.72		0.9	0.97	0.72	-0.7	0.78	-0.87
Capital Stock	0.9	0.77	-0.26	0.01	0.9	0.92	-0.92	-0.9	0.58	0.9	0.43	0.9	0.73	-0.76	0.05	0.9	-0.18	0.9	0.81	0.9		0.9	0.81	-0.69	0.83	-0.57
Net Working Capital	0.97	0.59	-0.31	-0.13	1.0	0.99	-0.99	-0.93	0.41	0.98	0.38	0.98	0.75	-0.83	-0.21	0.97	-0.3	1.0	0.59	0.97	0.9		0.59	-0.54	0.66	-0.84
Short Term Debt	0.72	0.94	0.2	0.54	0.59	0.58	-0.68	-0.8	0.91	0.69	0.5	0.69	0.67	-0.47	0.59	0.72	0.34	0.62	1.0	0.72	0.81	0.59		-0.84	0.99	-0.4
Common Stock	-0.7	-0.97	-0.45	-0.66	-0.52	-0.5	0.62	0.78	-0.89	-0.68	-0.86	-0.68	-0.5	0.18	-0.56	-0.7	-0.55	-0.57	-0.84	-0.7	-0.69	-0.54	-0.84		-0.82	0.5
Current Deferred Revenue	0.78	0.92	0.15	0.5	0.66	0.64	-0.74	-0.84	0.9	0.75	0.46	0.75	0.7	-0.55	0.54	0.78	0.29	0.69	0.99	0.78	0.83	0.66	0.99	-0.82		-0.48
Non Currrent Assets Other	-0.87	-0.47	-0.03	-0.11	-0.83	-0.75	0.83	0.83	-0.42	-0.87	-0.44	-0.87	-0.63	0.58	0.12	-0.86	-0.01	-0.85	-0.4	-0.87	-0.57	-0.84	-0.4	0.5	-0.48

Click cells to compare fundamentals

Tharimmune Account Relationship Matchups

Pair Trading with Tharimmune

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Tharimmune position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tharimmune will appreciate offsetting losses from the drop in the long position's value.

Moving together with Tharimmune Stock

0.66

FDMT

4D Molecular Therapeutics

Pair Corr

Moving against Tharimmune Stock

0.6	OPT	Opthea	Pair Corr
0.46	NAMS	NewAmsterdam Pharma	Pair Corr
0.45	BMY	Bristol Myers Squibb Aggressive Push	Pair Corr

The ability to find closely correlated positions to Tharimmune could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Tharimmune when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Tharimmune - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Tharimmune to buy it.

The correlation of Tharimmune is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Tharimmune moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Tharimmune moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Tharimmune can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

Additional Tools for Tharimmune Stock Analysis

When running Tharimmune's price analysis, check to measure Tharimmune's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tharimmune is operating at the current time. Most of Tharimmune's value examination focuses on studying past and present price action to predict the probability of Tharimmune's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tharimmune's price. Additionally, you may evaluate how the addition of Tharimmune to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC